From: Persistent organic pollutants as risk factors for type 2 diabetes
Reference | Location | Population/ setting | Age (years) | Diagnostic criteria of diabetes | Confounders | Total population | Diabetic population | Proportion of men % | Compounds measured | Compounds with statistical significant difference | Â | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  |  |  |  |  | PCBs | Dioxins | OC pesticides | others |
[20] | Sweden | Fishermen and their wives from the Swedish east coast | 66.5 | Self-reported physician-diagnosed diabetes | Age, sex, BMI | 380 | 22 | 51.6 | PCB-153,p,p ′ -DDE | PCB-153 OR = 1.16, 95% CI (1.03-1.32) |  | p,p'-DDE OR = 1.05, 95% CI 1.01- 1.09). |  |
[8] | USA | NHANES (1999 – 2002) | ≥20 | FPG ≥ 126 mg/dl, Non-fasting glucose ≥200 mg/dl, Self-reported physician-diagnosed diabetes | Age, sex, BMI, race/ethnicity, poverty income ratio, WC | 2,016 | 217 | NA | PCB-153, HpCDD, OCDD, oxychlordane, DDE, trans-nonachlor | PCB-153 OR = 6.8, 95% CI (3.0–15.5) | HpCDD OR = 2.7, 95% CI (1.3–5.5) | Oxychlordane OR = 6.5 (2.0–21.4) DDE OR = 4.3, 95% CI (1.8–10.2);trans- nonachlor OR = 11.8, 95%CI (4.4–31.3) |  |
[9] | USA | Mohawk adults (one adult/ household) | 57.5 | FPG >125 mg/dl, Taking prescribed glucose-lowering medication | Age, sex, BMI, serum lipid levels, smoking history | 352 | 71 | 38.1 | Total PCB, PCB-153, PCB-74, DDE, HCB, mirex , | Total PCB, OR = 3.9,95% CI (1.5–10.6). PCB-153 OR = 3.2, 95% CI (1.3–8.2) PCB-74 OR = 4.9, 95% CI (1.7–13.7) |  | DDE, OR = 6.4, 95%CI (2.2–18.4) HCB OR = 6.2, 95%CI (2.3–16.9) |  |
[21] | USA | NHANES (1982– 1984), Hispanic Americans | 47 | Self-reported physician diagnosed diabetes | Age, sex, BMI, place of birth, education, poverty index | 1,303 | 89 | 40.5 | p,p ′ -DDT, p,p ′ -DDE, dieldrin, oxychlordane, β -HCH, HCB, trans-nonachlor |  |  | p,p ′ -DDT (OR = 2.3,95% CI(1.1–5.0) , p,p ′ -DDE, OR = 2.63, 95% CI (1.2–5.8) β -HCH, OR = 2.7, 95% CI (0.9–8.2), oxy chlordane OR = 3.3, 95% CI (1.2–8.7) trans nonachlor OR = 3.4, 95% CI (1.4–7.9) |  |
Lee et al. [61] | USA | NHANES (1999 – 2002) | ≥20 | FPG ≥ 126 mg/dl, non-fasting glucose ≥ 200 mg/dl, Self-reported physician-diagnosed diabetes | Age, sex, BMI, race/ethnicity, poverty income ratio, WC | 1,721 | 179 | NA | PCDDs (3), PCDFs (3), dioxin-like PCBs (4), nondioxin-like PCBs (5),OC pesticides (4) | Dioxin-like PCBs OR = 15.7, 95% CI (3.4–71.2) |  | Oxychlordane, OR = 4.6, 95% CI (2.0–10.4),trans nonachlor, β –HCH Or = 7.0, 95% CI (2.7–18.1); DDT OR = 2.9, 95% CI (1.5–5.6), |  |
[23] | Sweden | Swedish fishermen’s wives | 44 | Self-reported diabetes | Age and BMI | 544 women | 16 | 0.0 | CB-153 and p,p-DDE |  |  | CB-153; OR = 1.6, 95% CI (1. 0–2. 7) and p,p-DDE OR = 1.3, 95% CI (1. 1–1.6) |  |
[7] | USA | National Health and Nutrition Examination Survey 2003–2004 | 69 | Fasting plasma glucose ≥126 mg/dl non-fasting plasma glucose ≥200 mg/dl , taking insulin or an oral agent. | Age, sex, race, poverty income ratio, and BMI | 1,367 | 156 | 47.3 | PBB-153 PBDE-28 PBDE-47 PBDE-99 PBDE-100 PBDE-153 |  |  |  | PBB-153 OR = 1.9, 95% CI (0.9–4.0) |
[26] | Japan | Survey (2002 – 2006) | 44 | Self-reported physician diagnosed diabetes, non-diagnosed participants with plasma HbA 1c >6.1% | age, gender, log (BMI), smoking habit, regional block, residential area, and survey year | 1374 | 65 | 45.6 | 7 PCDDs, 10 PCDFs, 12 dioxin-like PCBs | 12 dioxin-like PCBs OR = 6.82, 95% CI (2.59–20.1) | 7 PCDDs,10 PCDFs OR = 2.21, 95% CI (1.02–5.04), |  |  |
[30] | Taiwan | Yu Cheng cohort (1993 – 2003) | 55.5 | Self-reported physician-diagnosed diabetes | age, BMI, cigarette smoking, and alcohol intake | 748 | 144 | 41.0 | Total PCB | Total PCB in women [OR 2.1,95% CI (1.1– 4.5) |  |  |  |
[62] | South Korea | Community-based health survey | 55.6 | FPG ≥ 126 mg/dL, taking antidiabetic medication | age, sex, BMI, alcohol consumption, and cigarette smoking. | 80 | 40 | 52.5 | β-hexachlorocyclohexane, HCB, heptachlor epoxide, p,p′-DDE, p,p′-DDD, p,p′-DDT, o,p′-DDT, oxychlordane, trans-nonachlor, and mirex |  |  | p,p′-DDE OR = 12.7, 95% CI (1.9–83.7),p,p′-DDT OR = 10.6, (1.3–84.9), o,p′-DDT OR = 12.3, 95% CI (1.3–113.2);oxychlordane, OR = 26.0, 95% CI (1.3–517.4); trans-nonachlor OR = 8.1, 95% CI (1.2–53.5) and heptachlor epoxide OR = 3.1, 95% CI (0.8–12.1) |  |
[19] | Slovakia | heavily polluted Slovakian district of Michalovce and two reference districts (Svidnik and Stropkov) | 48 | FPG >7.0 mmol/l (all participants) and 2 h glucose >11.1 mmol/l (OGTT, 60% of participants) | Age, sex, BMI | 2,047 | 296 | 40.8 | PCBs (15), p,p ′ -DDE, p,p ′ -DDT, HCB, β -HCH | Total PCBs OR = 2.74,95% CI (1.92 – 3.90) |  | p,p ′ -DDE, OR = 1.86,95% CI (1.17 – 2.95);p,p ′ -DDT OR = 2.48,95% CI (1.77–3.48) |  |
[24] | Finland | Helsinki Birth Cohort Study representing a general adult urban Finnish population | 63.5 | fasting plasma glucose ≥7.0 mmol/L or 2-h plasma glucose ≥11.1 mmol/L or on anti-diabetic medication. | Sex, age, WC and mean arterial pressure | 1,988 | 308 | 46.3 | oxy-chlordane, trans nonachlor, p,p’ -DDE, PCB 153, BDE 47, and BDE153 | PCB 153 OR = 1.64 (0.92 – 2.93) P = 0.050 |  | Oxy chlordane OR = 2.08, 95% CI (1.18 – 3.69); trans nonachlor OR = 2.24, 95% CI (1.25 – 4.03); DDE OR = 1.75, 95% CI (0.96 – 3.19) |  |
[25] | Japan | Participants in the Saku Control Obesity Program. | 52 | HbA1c level ≥ 6.9% ,taking medication for diabetes, fasting plasma glucose ≥ 126 mg/dL, or a history of doctor-diagnosed diabetes | Sex, age, BMI and total lipids. | 117 | 32 | 50.4 | PCB 74, 99, 118, 138, 146, 153, 156, 163/164, 170, 180 and 182/187 | PCB 146, OR = 2.46, 95% CI (1.09-5.59) PCB 180 OR = 1.39, 95% CI (1.10-1.76) |  |  |  |
[34] | Denmark | The Gentofte population and Odense population | 52.2 | FPG ≥ 7.0 mmol/liter on two occasions, absence of anti-glutamic acid decarboxylase 65 antibodies, and no need for insulin therapy | Age, sex, and percent body fat, study site | 148 | 31 | 64.3 | HCB, HCH, p’p’-DDE, op’-DDE, p’p’-DDT, PCB-105, 118 and 156, PCB-101, 138, 153 and 180 | PCB-105 OR = 3.8, 95% CI (3.0–4.9) PCB 118 OR = 14.2, 95% CI (10.2–21.0) |  | organochlorine HCB, OR = 28.0, 95% CI (20.0–39.7);p’,p’-DDE OR = 139.4,95% CI (73.6–288.4) |  |
[63] | Spain | Participants of the Catalan Health Interview Survey (CHIS) | 46 | FPG ≥ 126 mg/dL, reported physician diagnosed diabetes and current use of insulin or antidiabetic medication | age, sex, and BMI,total cholesterol and triglycerides | 886 | 143 | 42.9 | op-‘-DDT, p,p ′ -DDT, o,p′ -DDE, p,p ′ -DDE, o,p′ -DDD, p,p ′ -DDD; PCB28, 52, 101, 118, 138, 153, and 180, PeCB, HCB, α –HCH, β -HCH, γ -HCH, and δ -HCH | Non dioxin like PCBs (PCB28, 52, 101, 118, 138, 153, and 180,) OR = 1.8, 95% CI (1.2 − 2.7) |  | op-‘-DDT, o,p ′ -DDE, o,p ′ -DDD, p,p ′ -DDD; HCB, α –HCH,, γ -HCH, and δ –HCH OR = 1.8, 95% CI (1.0 − 3.2) |  |
[6] | USA | Employed at the La Salle Electrical Utilities Company in illinios and local residents not previously employed | 57 | self-reported diagnosed diabetes, and/or fasting glucose ≥ 126 mg/dL | age, BMI, alcohol use, smoking, high blood pressure, total lipids, medication use | 63 | 7 | 100 | 6 dioxin-like PCBs and 33 non dioxin like PCBs | All PCBs OR = 3.0, 95% CI (1.3-7.2) |  |  |  |
[18] | USA | Anniston, Alabama general population | 55.5 | fasting glucose values > 125 mg/dL, self-reported or physician diagnosed diabetes | Age, sex, race/ ethnicity, or BMI | 774 | 207 | 30.0 | 35 PCB ortho-substituted congeners, DDE | All PCBs 2.78,95% CI(1.00-7.73) |  | DDE OR = 1.22, 95% CI(0.85-1.46) |  |
[64] | Spain | San Cecilio University Hospital in thecity of Granada and Santa Ana Hospital in the town of Motril | 55 | self-reported information and clinical records showing a fasting glucose level Z 126 mg/dL in the routine analyses | Adipose tissue origin , sex, age, and BMI | 386 | 34 | 51.0 | PCB-138, PCB-153, PCB-180, HCB, b-HCH, p,p’-DDE, |  |  | p,p‘-DDE OR = 4.4, 95% CI (1.0–21.0) |  |
[65] | Canada | Wapekeka and Kasabonika two of the five Shibogama communities in northern Ontario | 44.5 | resting plasma glucose >7.0 mmol/L and/or a post-prandial level (2 hours after glucose ingestion) > 11.0 mmol/L | Age, BMI and smoking status | 72 | 26 | 43.1 | Aroclor 1260, PCB28, 52, 99, 101, 105, 118, 128, 138,153, 156, 163, 170, 180,183,187,aldrin, − αchlordane, β-chlordane, − β-HCH, cis-nonachlor, trans-nonachlor, DDE, DDT, HCB,mirex, oxychlordane, PBB153, PBDE47, 99, 100,153, Parlar26, and Parlar50. | PCB28, 52, 99, 101, 118, 128, 138, 153, 156, 163, 170, 180, 183,187, |  | Trans nonachlor, DDE, oxychlordane, all p < 0.05 |  |
[66] | South Korea | NA | NA | FPG ≥ 126 mg/dL, reported history of physician-diagnosed diabetes | age , sex, alcohol consumption , cigarette smoking and BMI | 50 | 25 | 48.0 | 14 OC pesticides, 22 PCB congeners |  |  | DDTs in VAT, OR = 9.0,95% CI(1.3–62.9) |  |
 | South Korea | Community-based health survey | 55.6 | FPG ≥ 126 mg/dL, taking antidiabetic medication | age, sex, BMI, alcohol consumption, and cigarette smoking. | 80 | 40 | 52.5 | β-hexachlorocyclohexane, HCB, heptachlor epoxide, p,p′-DDE, p,p′-DDD, p,p′-DDT, o,p′-DDT, oxychlordane, trans-nonachlor, and mirex |  |  | p,p′-DDE OR = 12.7, 95% CI (1.9–83.7);p,p′-DDT OR = 10.6, 95% CI (1.3–84.9);o,p′-DDT OR = 12.3, 95% CI (1.3–113.2);oxychlordane, OR = 26.0, 95% CI (1.3–517.4); trans-nonachlor OR = 8.1, 95% CI (1.2–53.5) and heptachlor epoxide OR = 3.1, 95% CI (0.8–12.1) |  |